Journals of the American Society for Pharmacology...
Transcript of Journals of the American Society for Pharmacology...
Journals of theAmerican Society for Pharmacology
and Experimental Therapeutics
Widely Read and Highly Respected
www.aspetjournals.org
Feeds Now Available from all ASPET Journals!
Feed options include:
• Current Issue (all journals) • Recent Issues (all journals) • Fast Forward Articles (JPET,
PharmRev, MolPharm, & DMD) • Subject Headings (JPET)
Keep up with the latest content from ASPET’s journals
Use the orange RSS feed link on each journal’s homepage
Instructions and links to available RSS feed readers are provided
RSS
Statement of Ownership, Management, and Circulation (All Periodicals Publications Except Requester Publications) 1. Publication Title: Pharmacological Reviews. 2. Publication Number: 0031-6997. 3. Filing Date: September 8, 2008. 4. Issue Frequency: quarterly in March, June, September, and December. 5. Number of Issues Published Annually: 4. 6. Annual Subscription Price: $256.00. 7. Complete Mailing Address of Known Office of Publication: American Society for Pharmacology and Experimental Therapeutics, 9650 Rockville Pike, Bethesda, MD 20814-3995. Contact Person: Richard Dodenhoff. Telephone: 301-634-7997. 8. Complete Mailing Address of Headquarters or General Business Office of Publisher: American Society for Pharmacology and Experimental Therapeutics, 9650 Rockville Pike, Bethesda, MD 20814-3995. 9. Full Names and Complete Mailing Addresses of Publisher, Editor, and Managing Editor: Publisher: American Society for Pharmacology and Experimental Therapeutics, 9650 Rockville Pike, Bethesda, MD 20814-3995. Editor: Dr. Ross D. Feldman, Robarts Research Institute, PO Box 5015, Stn. B, 100 Perth Dr., London N6A 5K8, ON, Canada. Managing Editor: Jill Filler, American Society for Pharmacology and Experimental Therapeutics, 9650 Rockville Pike, Bethesda, MD 20814-3995. 10. Owner: American Society for Pharmacology & Experimental Therapeutics, 9650 Rockville Pike, Bethesda, MD 20814-3995. 11. Known Bondholders, Mortgagees, and Other Security Holders Owning or Holding 1 Percent or More of Total Amount of Bonds, Mortgages, or Other Securities: None. 12. Tax Status: The purpose, function, and nonprofit status of this organization and the exempt status for federal income tax purposes: Has Not Changed During Preceding 12 Months. 13. Publication Title: Pharmacological Reviews. 14. Issue Date for Circulation Data: June 2008. 15. Extent and Nature of Circulation: Average No. Copies Each Issue During Preceding 12 Months: a. Total Number of Copies: 1,182. b. Paid Circulation: (1) Mailed Outside-County Paid Subscriptions Stated on PS Form 3541: 641. (2) Mailed In-County Paid Subscriptions Stated on PS Form 3541: 0. (3) Paid Distribution Outside the Mails Including Sales Through Dealers and Carriers, Street Vendors, Counter Sales, and Other Paid Distribution Outside USPS®: 306. (4) Paid Distribution by Other Classes of Mail Through the USPS: 0. c. Total Paid Distribution: 947. d. Free or Nominal Rate Distribution: (1) Free or Nominal Rate Outside-County Copies Included on PS Form 3541: 11; (2) Free or Nominal Rate In-County Copies Included on PS Form 3541: 0; (3) Free or Nominal Rate Copies Mailed at Other Classes Through the USPS: 0; (4) Free or Nominal Rate Distribution Outside the Mail: 5. e. Total Free or Nominal Rate Distribution: 16. f. Total Distribution: 963. g. Copies not Distributed: 220. h. Total: 1,182. i. Percent Paid: 98.3641. No. Copies of Single Issue Published Nearest to Filing Date: a. Total Number of Copies: 990. b. Paid Circulation: (1) Mailed Outside-County Paid Subscriptions Stated on PS Form 3541: 551; (2) Mailed In-County Paid Subscriptions Stated on PS Form 3541: 0; (3) Paid Distribution Outside the Mails Including Sales Through Dealers and Carriers, Street Vendors, Counter Sales, and Other Paid Distribution Outside USPS®: 256; (4) Paid Distribution by Other Classes of Mail Through the USPS: 0. c. Total Paid Distribution: 807. d. Free or Nominal Rate Distribution: (1) Free or Nominal Rate Outside-County Copies Included on PS Form 3541: 11; (2) Free or Nominal Rate In-County Copies Included on PS Form 3541: 0; (3) Free or Nominal Rate Copies Mailed at Other Classes Through the USPS: 0; (4) Free or Nominal Rate Distribution Outside the Mail: 4. e. Total Free or Nominal Rate Distribution: 15. f. Total Distribution: 822. g. Copies not Distributed: 168. h. Total: 990. i. Percent Paid: 98.1752. 16. Publication of Statement of Ownership If the publication is a general publication, publication of this statement is required. Will be printed in the September 2008 issue of this publication. 17. Signature and Title of Editor, Publisher, Business Manager, or Owner: Richard C. Dodenhoff II, Journals Director. September 8, 2008. I certify that all information furnished on this form is true and complete. I understand that anyone who furnishes false or misleading information on this form or who omits material or information requested on the form may be subject to criminal sanctions (including fines and imprisonment) and/or civil sanctions (including civil penalties).
Advertise in the publications of the American Society for Pharmacology and ExperimentalTherapeutics (ASPET). Receive a FREE posting on the ASPET website for 8 weeks with a paidline ad in ASPET’s member magazine Molecular Interventions (MI).
•MI is read by over 4,400 members•Line ads, web postings, and email ads availabe•Line ads only $12 per line in MI•Online postings up within a couple days•Email ads only $250 per issue
CONTACT FASEB AdNet at 301-634-7156 or email [email protected] for an ad estimate.
View ASPET rate card and full media kit at www.faseb.org/adnet.
Need to promote open positions, fellowship opportunities,programs, or conferences in pharmacology?
SSTTAAYY CCOONNNNEECCTTEEDD......
HHAAVVEE YYOOUU MMOOVVEEDD??CCHHAANNGGEEDD YYOOUURR EEMMAAIILL AADDDDRREESSSS??
CCHHAANNGGEEDD JJOOBBSS??BBee ssuurree ttoo kkeeeepp uuss iinnffoorrmmeedd ooff aannyy
cchhaannggeess ttoo yyoouurr iinnffoorrmmaattiioonn ssoo tthhaatt yyoouuddoonn’’tt mmiissss aa ssiinnggllee iissssuuee ooff yyoouurr AASSPPEETT
JJoouurrnnaall ssuubbssccrriippttiioonnss!!!!EEMMAAIILL UUSS:: IINNFFOO@@AASSPPEETT..OORRGG
ASPET Membership The Benefits Add Up!
ASPET Membership Includes Online Access to: Journal of Pharmacology and Experimental Therapeutics Pharmacological Reviews Molecular Pharmacology Drug Metabolism and Disposition Molecular Interventions (print subscription also included)
Members Save 50% on Page Charges and Color Fees $40/page for members versus $80 for nonmembers $200/figure for members versus $400 for nonmembers Includes JPET, Molecular Pharmacology, and DMD Reduced Registration Fees for ASPET Meetings — Including Experimental Biology
Public Affairs Advocacy for Increased Research Funding and Science Policy Favorable to Biomedical Research — Public policy reports provided regularly
Personal print subscriptions are available only to ASPET Members: Journal of Pharmacology and Experimental Therapeutics - $210 Pharmacological Reviews - $89 Drug Metabolism and Disposition - $112 Molecular Pharmacology - $152
Apply for membership online at www.aspet.org
9650 Rockville Pike, Bethesda, MD 20814-3995 [email protected] (P) 301-634-7060 (F) 301-634-7061
Includes access to all
archival issues going back to volume 1, issue 1,
of each journal
For ASPET Members
Only!
The savings from one article pay for a year’s
dues
SSAAVVEE TTHHEE DDAATTEE!!!!22000099 AASSPPEETT AAnnnnuuaall MMeeeettiinngg
aatt EExxppeerriimmeennttaall BBiioollooggyy 22000099AApprriill 1188 -- 2222
NNeeww OOrrlleeaannss,, LLoouuiissiiaannaa22000099 SSyymmppoossiiaa::
A Renaissance in Marine Pharmacology: Preclinical Curiosity to Clinical Reality
Advances in Down Syndrome Neuroscience Research: Implications for Alzheimer'sDisease, Dementias, & Other Cognitive Disorders
All Presidents' Symposium on Integrative Pharmacology
AMPK as a Novel Therapeutic Approach for the Treatment of Metabolic Disorders & Heart Disease
Discovery & Development of Oligonucleotide Therapeutics
Emerging Approaches to Treatment of Alzheimer’s Disease
Endothelial Progenitor Cells & Cardiovascular Disease - From Bench to Bed Site
Exposure to Environmental Agent Alters Epigenetic Homeostasis
Gases as Neuromodulators in Sensing: From Nitric Oxide to Hydrogen Sulfide
Generating Proteomic Diversity in Xenobiotic Biotransformation with Alternative RNA Splicing
Integrating Basic Sciences & Patient Care in a Core Clerkship Curriculum
Metabolomics in the Search for Biomarkers for Human Health
microRNAs as Biological Effectors & as Pharmacological Targets in the Cardiovascular System
Neuroplastic & Neurodegenerative Changes Associated with Drug Abuse and Addiction
Receptor Signaling & Regulation in Neuropsychiatric Research
Regenerative Pharmacology
Regulation of Xenobiotic Metabolizing Enzymes in Humans: Implications for thePropagation of Health & Disease
Targeting Drug Metabolizing Enzymes for Effective Chemopreventive Approaches
The Role of Nuclear Receptors in Lipid Homeostasis
The Role of Insulin & Leptin in Drug Addiction and Mood
The Serotonin Transporter: Non Just for Neurons Anymore
Therapeutics in Autoimmunity: Treatment Successes & Side Effects as a Tool ofElucidating Pathogenic Pathways
Virally-encoded G Protein Coupled Receptors as New Drug Targets?
SSeeee YYoouu iinn tthhee BBiigg EEaassyy!!!!FFoorr mmoorree IInnffoo:: wwwwww..eebb22000099..oorrgg
Photos Courtesy of New OrleansConvention and Visitors Bureau